Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Shehu, 2011, The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells, Mol Endocrinol, 25, 754, 10.1210/me.2010-0261 Kabos, 2012, Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures, Breast Cancer Res Treat, 135, 415, 10.1007/s10549-012-2164-8 Nilsson, 2001, Mechanisms of estrogen action, Physiol Rev, 81, 1535, 10.1152/physrev.2001.81.4.1535 Yager, 2006, Estrogen carcinogenesis in breast cancer, N Engl J Med, 354, 270, 10.1056/NEJMra050776 Liang, 2018, Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609), J Hematol Oncol, 11, 124, 10.1186/s13045-018-0670-9 Howlader, 2014, US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status, J Natl Cancer Inst, 106, dju055, 10.1093/jnci/dju055 Craven, 2008, PGRMC1: a new biomarker for the estrogen receptor in breast cancer, Breast Cancer Res, 10, 10.1186/bcr2191 Ferreira Almeida, 2020, Estrogen receptor-positive (ER+) breast cancer treatment: are multi-target compounds the next promising approach?, Biochem Pharmacol, 117 AlFakeeh, 2018, Overcoming endocrine resistance in hormone receptor-positive breast cancer, Curr Oncol, 25, S18, 10.3747/co.25.3752 Mueck, 2014, Genomic and non-genomic actions of progestogens in the breast, J Steroid Biochem Mol Biol, 142, 62, 10.1016/j.jsbmb.2013.08.011 Wang, 2014, G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids, Int J Mol Sci, 15, 15412, 10.3390/ijms150915412 Cenciarini, 2019, Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation, Steroids, 152, 108503, 10.1016/j.steroids.2019.108503 Wilkenfeld, 2018, Communication between genomic and non-genomic signaling events coordinate steroid hormone actions, Steroids, 133, 2, 10.1016/j.steroids.2017.11.005 Liu, 2013, Estrogen-induced nongenomic calcium signaling inhibits lipopolysaccharide-stimulated tumor necrosis factor α production in macrophages, PLoS ONE, 8, e83072, 10.1371/journal.pone.0083072 Pang, 2013, Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and {epsilon} (mPRδ and mPR{epsilon}) and mPRδ involvement in neurosteroid inhibition of apoptosis, Endocrinology, 154, 283, 10.1210/en.2012-1772 Mir, 2012, Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients, Int J Cancer, 131, E1, 10.1002/ijc.26432 Peluso, 2008, Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1, J Clin Endocrinol Metab, 93, 1592, 10.1210/jc.2007-2771 Crudden, 2005, Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors, Tumour Biol, 26, 142, 10.1159/000086485 Ruan, 2017, Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer, Menopause, 24, 203, 10.1097/GME.0000000000000739 Ji, 2012, [Expression of progesterone receptor membrane component-1 is associated with the malignant phenotypes of breast cancer], Nan Fang Yi Ke Da Xue Xue Bao, 32, 635 Pedroza, 2020, Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling, Br J Cancer, 123, 1326, 10.1038/s41416-020-0992-6 Ruan, 2012, Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells, Gynecol Endocrinol, 28, 863, 10.3109/09513590.2012.671396 Zhou, 2013, Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1, Maturitas, 76, 129, 10.1016/j.maturitas.2013.06.013 Ruan, 2012, Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells, Climacteric, 15, 467, 10.3109/13697137.2011.648232 Schneck, 2013, Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells, Gynecol Endocrinol, 29, 160, 10.3109/09513590.2012.730572 Neubauer, 2013, Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy, Menopause, 20, 504, 10.1097/gme.0b013e3182755c97 Willibald, 2017, Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells, Oncotarget, 8, 72480, 10.18632/oncotarget.19819 Li, 2019, PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol, Climacteric, 22, 483, 10.1080/13697137.2019.1582624 Ciriello, 2015, Comprehensive molecular portraits of invasive lobular breast cancer, Cell, 163, 506, 10.1016/j.cell.2015.09.033 Mote, 2002, Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis, Breast Cancer Res Treat, 72, 163, 10.1023/A:1014820500738 Mote PA, Graham JD, Clarke CL. Progesterone receptor isoforms in normal and malignant breast. Ernst Schering Found Symp Proc. 2007:77–107. McGowan, 2004, Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts, Breast Cancer Res Treat, 83, 211, 10.1023/B:BREA.0000014041.58977.80 Khan, 2012, Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line, PLoS ONE, 7, e45993, 10.1371/journal.pone.0045993 Kariagina, 2008, Progesterone receptor isoform functions in normal breast development and breast cancer, Crit Rev Eukaryot Gene Expr, 18, 11, 10.1615/CritRevEukarGeneExpr.v18.i1.20 Ahmed, 2010, Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity, J Biol Chem, 285, 24775, 10.1074/jbc.M110.134585 Meyer, 1990, Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor, EMBO J, 9, 3923, 10.1002/j.1460-2075.1990.tb07613.x Neubauer, 2008, Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1, Breast Cancer Res, 10, 10.1186/bcr2155 Mifsud, 2002, Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain, Genome Biol, 3, 10.1186/gb-2002-3-12-research0068 Min, 2005, Molecular identification of adrenal inner zone antigen as a heme-binding protein, FEBS J, 272, 5832, 10.1111/j.1742-4658.2005.04977.x Hughes, 2007, Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes, Cell Metab, 5, 143, 10.1016/j.cmet.2006.12.009 Selmin, 1996, Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver, Carcinogenesis, 17, 2609, 10.1093/carcin/17.12.2609 Cahill, 2007, Progesterone receptor membrane component 1: an integrative review, J Steroid Biochem Mol Biol, 105, 16, 10.1016/j.jsbmb.2007.02.002 Osborne, 1998, Tamoxifen in the treatment of breast cancer, N Engl J Med, 339, 1609, 10.1056/NEJM199811263392207 Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., 2005, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, 365, 1687, 10.1016/S0140-6736(05)66544-0 Fan, 2015, Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies, Future Med Chem, 7, 1511, 10.4155/fmc.15.93 Bardou, 2003, Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases, J Clin Oncol, 21, 1973, 10.1200/JCO.2003.09.099 Mohammed, 2015, Progesterone receptor modulates ERα action in breast cancer, Nature, 523, 313, 10.1038/nature14583 Shah, 2003, Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden, Cancer, 98, 1552, 10.1002/cncr.11697 Busund, 2018, Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: the Norwegian Women and Cancer Study, Int J Cancer, 142, 2293, 10.1002/ijc.31266 Nachtigall, 2018, Contemporary hormonal contraception and the risk of breast cancer, N Engl J Med, 378, 1265 Blank, 2008, Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats, Proc Natl Acad Sci USA, 105, 3527, 10.1073/pnas.0710535105 Chlebowski, 2015, Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 women's health initiative randomized clinical trials, JAMA Oncol, 1, 296, 10.1001/jamaoncol.2015.0494 Boopalan, 2015, Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis, Cancer Sci, 106, 25, 10.1111/cas.12571 Schwartz, 2016, Rapid steroid hormone actions via membrane receptors, Biochim Biophys Acta, 1863, 2289, 10.1016/j.bbamcr.2016.06.004 Christ, 1995, Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha, Biochem Biophys Res Commun, 213, 123, 10.1006/bbrc.1995.2106 Kousteni, 2001, Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity, Cell, 104, 719 Kaluka, 2015, Spectroscopic and mutagenesis studies of human PGRMC1, Biochemistry, 54, 1638, 10.1021/bi501177e Asperger, 2020, Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression, Breast Cancer Res, 22, 10.1186/s13058-020-01312-8 Carneiro, 1993, Age-related changes in melatonin modulation of sympathetic neurotransmission, J Pharmacol Exp Ther, 266, 1536 Ahmed, 2012, S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling, Expert Opin Drug Metab Toxicol, 8, 361, 10.1517/17425255.2012.658367 Payne, 2004, Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones, Endocr Rev, 25, 947, 10.1210/er.2003-0030